ZOLL Announces Five-Year Study Confirming Safety, Efficacy and Beneficial Effects of Long-Term Transvenous Phrenic Nerve Stimulation (the Remedē System)

Matt Hogan ZOLL Medical Corporation +1 (978) 805-6561 [email protected]